Biotech firm Odyssey valued at $899.9 million as shares rises in Nasdaq debut
Kailera Therapeutics, Inc.
Odyssey Therapeutics, Inc.
Alamar Biosciences, Inc.
Kailera Therapeutics, Inc. KLRA | 0.00 | |
Odyssey Therapeutics, Inc. ODTX | 0.00 | |
Alamar Biosciences, Inc. ALMR | 0.00 |
May 8 (Reuters) - Odyssey Therapeutics ODTX.O shares rose 11.1% in its Nasdaq debut on Friday, giving the biopharmaceutical firm a valuation of $899.9 million.